About Metagenomi, Inc. 
Metagenomi, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 18 Schemes (7.58%)
Foreign Institutions
Held by 25 Foreign Institutions (9.12%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Mar 2026)
Net Profit:
-23 Million
Pharmaceuticals & Biotechnology
USD 50 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.98
-54.59%
0.31






